Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Tech Gazette.
Press releases published on April 7, 2025
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
GlobeNewswire
·
April 7, 2025
Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in Rheumatology Dual CD19/CD70 CAR T Specifically Designed to Enhance Therapeutic Benefit, Expanding Treatment Potential Across a …
SEALSQ and WISeSat to Showcase Breakthrough Post-Quantum Satellite Technology at the 40th Annual Space Symposium in Colorado Springs
GlobeNewswire
·
April 7, 2025
Geneva, Switzerland, April 07, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, together with …
DeflationCoin Launches to Fix Bitcoin’s Flaws with Burn-Based Model and Smart Staking
GlobeNewswire
·
April 7, 2025
Dubai, UAE, April 07, 2025 (GLOBE NEWSWIRE) -- DeflationCoin formally launched a groundbreaking cryptocurrency with the purpose of fixing the economic and technological shortcomings of Bitcoin and Ethereum. The team is introducing a hard cap on the total …
Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center
GlobeNewswire
·
April 7, 2025
RA'ANANA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced the successful completion of …
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
GlobeNewswire
·
April 7, 2025
Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming to uncover new insights and optimize development pathways. NAPLES, Fla. and CAMBRIDGE, United …
Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations
GlobeNewswire
·
April 7, 2025
ASHBURN, Va., April 07, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), an authorized enrollment provider, continues to expand locations to enroll consumers in the TSA PreCheck® program by opening 10 new locations in California, Florida, Hawaii, …
American Rebel Holdings Issues Corporate Update Highlighting Recent Key Milestones and Strategic Growth Initiatives
GlobeNewswire
·
April 7, 2025
Forged in Freedom, Fueled by Growth, Focused on the Future NASHVILLE, TN, April 07, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), the creator of American Rebel Beer (americanrebelbeer.com) and a …
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
GlobeNewswire
·
April 7, 2025
Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells per treatment. After 12 months of treatment, both patients who completed 17 doses improved from moderate to mild AD within just 3 …
reAlpha Tech Corp. Announces Exercise of Warrants for $3.1 Million Gross Proceeds
GlobeNewswire
·
April 7, 2025
DUBLIN, Ohio, April 07, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, today announced the entry into …
MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors
GlobeNewswire
·
April 7, 2025
CARMEL, Ind., April 07, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
GlobeNewswire
·
April 7, 2025
SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer (CCO), effective May 1, …
CPI Aerostructures Delivers Airborne Pod Structure in Support of Northrop Grumman’s Airborne Laser Mine Detection Program for Korea
GlobeNewswire
·
April 7, 2025
EDGEWOOD, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) announced today that they completed production and delivery of an Airborne Laser Mine Detection System (ALMDS) pod structure for …
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025
GlobeNewswire
·
April 7, 2025
– Company generated quarterly sequential growth with Q1 YCANTH® dispensed applicator units rising above 10,000 for the first time in a quarter – – As YCANTH distributor inventory levels have normalized, Company expects that dispensed applicator units will …
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
GlobeNewswire
·
April 7, 2025
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform ALX2004, the company’s first ADC, was fully designed …
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
GlobeNewswire
·
April 7, 2025
SAN DIEGO and SUZHOU, China, April 07, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chairman, Chief Executive …
Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
GlobeNewswire
·
April 7, 2025
Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus’ Directors and Promote a Flawed Strategy Urges Stockholders to Vote on the BLUE Proxy Card FOR All Nine of the Company’s Nominees RESEARCH TRIANGLE PARK, N.C., April 07, …
Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology
GlobeNewswire
·
April 7, 2025
FLORHAM PARK, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced a key publication in the April 4, 2025, issue of the prestigious peer- …
CareCloud to Present at the LD Micro Invitational XV
GlobeNewswire
·
April 7, 2025
SOMERSET, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, is pleased to …
Aspargo Labs Expands Global Leadership Team
GlobeNewswire
·
April 7, 2025
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in …
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
GlobeNewswire
·
April 7, 2025
If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pediatric patients, addressing the high unmet need for …